Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

How to correct the market for children’s cancer drugs

Nature Medicine volume 28, page 613 (2022)Cite this article

Subjects

The development of pediatric cancer drugs is vastly underfunded compared with that for adults, but legislation can correct market failures.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Kids v Cancer, Washington, DC, USA

    Nancy F. Goodman

Authors
  1. Nancy F. Goodman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nancy F. Goodman.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goodman, N.F. How to correct the market for children’s cancer drugs. Nat Med 28, 613 (2022). https://doi.org/10.1038/s41591-022-01747-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-01747-w

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer